Other languages Zymeworks Inc.

Equities

ZYME

US98985Y1082

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
8.26 ^USD	+1.85%		-6.67%	-20.50%

Apr. 08	Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting	CI
Apr. 04	Zymeworks Inc. Removes Christopher Astle from the Positions of Chief Financial Officer	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting	Apr. 08
Zymeworks Inc. Removes Dr. Christopher Astle from the Positions of Senior Vice President	Apr. 04
Zymeworks Inc. Announces the Composition of the Committees	Mar. 28
Zymeworks Inc. Announces Appointment of Neil Gallagher to Its Board of Directors and as Member of the Research and Development Committee, Effective April 2, 2024	Mar. 28
Zymeworks Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06
Zymeworks Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06
Zymeworks Inc. to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting	Mar. 05
Zymeworks Inc. Appoints Scott Platshon as Director	Feb. 22
Zymeworks Announces Appointment of Dr. Alessandra Cesano to Its Board of Directors	Feb. 08
Zymeworks Insider Sold Shares Worth $257,845, According to a Recent SEC Filing	Jan. 09
Zymeworks Appoints Jeffrey Smith as Chief Medical Officer; Cash Runway Extended	Jan. 04
Zymeworks Inc Announces Additional Leadership Appointments	Jan. 04
Zymeworks Reports $50 Million Private Placement to EcoR1 Capital	Dec. 26
Zymeworks Expects to Be Added to Nasdaq Biotech Index	Dec. 15
Zymeworks Inc. Announces Changes to its Board	Dec. 08
Zymeworks Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07
Zymeworks Inc Announces Resignation of Lota Zoth as Member of the Board of Directors	23-10-16
Zymeworks Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Zymeworks Inc. Announces Board Changes, Effective June 30, 2023	23-06-29
Jazz Pharmaceuticals plc and Zymeworks Inc. Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers	23-06-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zymeworks Inc.

Equities

ZYME

US98985Y1082

Other languages

Filters